Pharmacological strategies in extracorporeal membrane oxygenation weaning failure: a call to action  

作　　者：Francisco J.González-Ruiz Francisco M.Baranda-Tovar Luis A.Baeza-Herrera JoséD.Utrilla-Álvarez Ricardo E.Quirázco-Cordova Gustavo Rojas-Velasco 

机构地区：[1]Department of Cardiovascular Critical Care,National Institute of Cardiology“Dr.Ignacio Chávez,”Mexico City,Mexico [2]National Institute of Cardiology.Juan Badiano 1,Belisario Dominguez Secc 16,Tlalpan,14080,Mexico City,Mexico

出　　处：《Emergency and Critical Care Medicine》2023年第2期43-45,共3页急危重症医学（英文）

摘　　要：Extracorporeal membrane oxygenation has emerged as a viable alternative for stabilizing and improving critically ill patients in acute cardiovascular diseases.However,the weaning stage has been associated with a high morbidity and mortality rate.This makes searching for strategies that reduce failure in this final process necessary.Implementing a new approach must be tried and included in our protocols,seeking the patient’s well-being at all times.In this article,the authors discuss their point of view regarding potential pharmacological alternatives and the mechanism of action involved,which could decrease the mortality associated with this therapeutic.

关 键 词：Β-BLOCKERS Extracorporeal membrane oxygenation Inodilators Mechanical circulatory support Pharmacological strategies 

分 类 号：R459.7[医药卫生—急诊医学]